Exporter Supply Landscape

Supplier countries for containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)

A reported trade view for HS 300310, with available observations through 2024.

HS6 300310Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

United Kingdom$140.3M

Supplier countries

190Reported suppliers

Top supplier reach

54Destination markets

Latest global trade

$491.7MYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
United Kingdom$140.3M+8.5%54Algeria
Switzerland, Liechtenstein$117.5M-44.4%8Iraq
China$103.6M+10.8%72Republic of Korea
Germany$92.3M+74.3%27Netherlands
Spain$78.6M+16.8%27Austria
Jordan$45.0M-37.7%2Sudan
France$33.7M-9.2%31Iraq
South Africa$19.0M+83.4%45United Arab Emirates
Japan$16.5M-13.8%5Belgium
Belgium$16.3M-18.5%17Italy
Austria$16.2M+9.7%14Croatia
Denmark$15.1M+18.4%9Poland
India$13.9M-6.5%67Algeria
Italy$13.2M-3.1%32Czechia
Syrian Arab Republic$13.2M+4.4%2Lebanon
Netherlands$11.2M+76.6%45Germany
USA$10.5M-8.9%60Iraq
Ireland$10.1M+145.6%13Iraq
Saudi Arabia$8.6M-14.2%5Sudan
Australia$8.0M+7.8%18New Zealand
Republic of Korea$7.7M+10.5%7Iraq
Slovenia$7.3M-78.1%2USA
Turkey$7.0M-5.4%6Sudan
Slovakia$6.6M+173.2%8Netherlands
Cyprus$5.3M-69.2%1Sudan
Brazil$4.8M+16.9%26Indonesia
Sweden$4.1M+15.2%5Sudan
New Zealand$4.0M-55.7%2Malta
Pakistan$3.6M+5.5%8Sudan
Panama$3.5M+58.5%5Aruba
Bulgaria$3.5M+20%3Indonesia
Lebanon$2.3M-85%0Saudi Arabia
Viet Nam$2.3M+5.7%2China
Qatar$2.1M-49.7%1Iran
Ethiopia$2.0M-71.7%0Sudan

Market reading

Which countries supply containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)?

United Kingdom is the leading reported supplier in this view, with exports of $140.3M.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale). The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
Egypt2023$42.5M231.4 t$183,727.87$132,957.75
Algeria2023$39.1M267.2 t$146,486.17$119,799.45
Morocco2023$18.1M103.4 t$174,885.41$174,885.41
Tunisia2023$10.4M46.4 t$222,960.44$157,408.89
France2023$8.7M54 t$160,198.95$135,413.04
Turkey2023$5.9M324.1 t$18,200.07$32,285.71
Libya2023$4.7M188.4 t$25,031.98$35,543.25
Republic of Korea2023$1.8M11.9 t$150,495.74$232,222.22
Italy2023$1.1M9.1 t$126,267.15$159,144.74
Luxembourg2023$300.5K16.3 t$18,414.17$128,600.34
Spain2023$168.7K0 t$12,047,928.57$113,896.83
Somalia2023$154.5K35 t$4,421.8$4,974.26
Saudi Arabia2023$87.0K0.8 t$108,770$135,640.5
Ireland2023$73.5K3.7 t$20,087.18$32,000
Germany2023$58.1K0 t$1,452,850$141,607.14
Ethiopia2023$48.1K0.4 t$120,347.5$120,347.5
Japan2023$46.1K0 t$3,549,538.46$443,962.38
Bahrain2023$44.1K0.6 t$73,503.33$152,938.27
Malaysia2023$40.5K0.1 t$623,153.85$13,500
Cayman Islands2023$39.9K0.5 t$88,130.24$125,600

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.